Myosin Therapeutics granted USD2m funding from Florida Department of Health
Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults
Hope Medicine reports first patient dosed in Phase III trial of HMI-115
Akeso's Phase II trials of AK146D1 and AK138D1 approved in China
Insilico Medicine and ASKA Pharmaceutical expand partnership on women's health targets
Pharming secures Japan approval for Joenja in rare immune disorder treatment
BioArctic and Eisai present new lecanemab and exidavnemab data at AD/PD 2026
HUTCHMED launches Phase III trial of HMPL-760 for DLBCL in China
Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate
Futura Medical reports positive home user test results for Eroxon and Intense variant
GSK secures Japan Orphan Drug status for lung cancer ADC
TheraCryf advances lead addiction programme to final preclinical stage
Dizal meets primary endpoint in Phase 3 study of ZEGFROVY (sunvozertinib) monotherapy
Innovent Biologics reports first participant dosed in tigulixostat Phase 3 study